Is a bootleg weight-loss drug to blame for 2 reported deaths?
Summary
The FDA received reports of two deaths in the U.S. linked to fake versions of retatrutide, an experimental weight-loss drug that is not yet approved. These counterfeit products are being sold online illegally, raising safety concerns as the true cause of death has not been confirmed.Key Facts
- Retatrutide is an experimental weight-loss drug developed by Eli Lilly, not approved by the FDA.
- Two deaths were reported after people took fake retatrutide obtained from unreliable sources.
- The first death involved a 41-year-old woman who suffered cardiac arrest; the second involved a 49-year-old woman who experienced severe dehydration, malnutrition, and cardiac arrest.
- Selling unapproved drugs like retatrutide is illegal, but counterfeit versions are widely available online and in some stores.
- Medical professionals have sometimes promoted access to retatrutide through non-regulated sellers.
- The FDA’s Adverse Event Reporting System collects such safety reports but does not confirm all details or causes.
- Exposure cases to retatrutide have increased sharply in recent months according to America’s Poison Centers.
- Experts warn that the illegal sale of such drugs bypasses safety and approval checks designed to protect patients.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
